Chemomab Therapeutics Ltd
CMMB
Company Profile
Business description
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet need. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.
Contact
Kiryat Atidim
Building 7
Tel Aviv 6158002
ISRT: +972 773310156
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2023
Employees
37
Stocks News & Analysis
stocks
7 charts on the AI stock boom one year after ChatGPT’s launch
These stocks and the key trends behind them are critical for understanding the AI investment landscape.
stocks
Why Berkshire Hathaway’s success will continue after Charlie Munger ... and Warren Buffett
Munger’s passing is a spiritual loss for the company.
stocks
Morningstar initiates coverage on 3 new shares
There are 2 undervalued names as part of our new coverage.
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 7,285.10 | 12.60 | -0.17% |
| CAC 40 | 7,344.28 | 33.51 | 0.46% |
| DAX 40 | 16,295.26 | 79.83 | 0.49% |
| Dow JONES (US) | 35,950.89 | 520.47 | 1.47% |
| FTSE 100 | 7,513.52 | 59.77 | 0.80% |
| HKSE | 16,830.30 | 212.58 | -1.25% |
| NASDAQ | 14,226.22 | 32.27 | -0.23% |
| Nikkei 225 | 33,431.51 | 55.38 | -0.17% |
| NZX 50 Index | 11,367.51 | 37.31 | 0.33% |
| S&P 500 | 4,567.80 | 17.22 | 0.38% |
| S&P/ASX 200 | 7,073.20 | 14.10 | -0.20% |
| SSE Composite Index | 3,031.64 | 1.96 | 0.06% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Pilbara Minerals Ltd PLS | 3.61 | 0.03 | -0.82% |
| Mirvac Group MGR | 2.04 | 0.02 | -0.97% |
| South32 Ltd S32 | 3.09 | 0.01 | 0.32% |
| Santos Ltd STO | 6.90 | 0.01 | -0.14% |
| Telstra Group Ltd TLS | 3.79 | 0.03 | -0.79% |
| Origin Energy Ltd ORG | 8.18 | 0.06 | -0.73% |
| Scentre Group SCG | 2.67 | 0.02 | 0.75% |
| Woodside Energy Group Ltd WDS | 30.84 | 0.16 | -0.52% |
| Qantas Airways Ltd QAN | 5.35 | 0.05 | 0.94% |
| Endeavour Group Ltd EDV | 5.00 | 0.07 | 1.42% |